Market Insights Digital Digital Health Digital Treatment & Care

Digital Therapeutics - Spain

Spain

Revenue in the Digital Therapeutics market is projected to reach €141.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 23.89%, resulting in a projected market volume of €333.60m by 2028.
User penetration will be 4.24% in 2024 and is expected to hit 8.78% by 2028.
The average revenue per user (ARPU) is expected to amount to €71.57.
In global comparison, most revenue will be generated in the United States (€2,877.00m in 2024).

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digital Therapeutics market in Spain is experiencing significant growth and evolution, driven by various factors shaping the healthcare landscape in the country.

Customer preferences: Customers in Spain are increasingly seeking digital solutions to manage chronic conditions such as diabetes, mental health disorders, cardiovascular issues, and musculoskeletal problems. The convenience, accessibility, and personalized nature of digital therapeutics appeal to a tech-savvy population looking for effective ways to improve their health outcomes.

Trends in the market: In Spain, there is a growing acceptance and adoption of digital therapeutics as an alternative or complementary approach to traditional pharmaceutical treatments. The market is witnessing a surge in the development of innovative digital solutions tailored to the specific healthcare needs of the Spanish population. Companies are focusing on creating user-friendly platforms and engaging content to enhance patient engagement and adherence to digital therapeutic interventions.

Local special circumstances: Spain's healthcare system is characterized by a strong emphasis on preventive care and patient-centered approaches. This aligns well with the objectives of digital therapeutics, which aim to empower individuals to take control of their health and well-being. The presence of a supportive regulatory environment and increasing collaborations between digital health companies and healthcare providers further fuel the growth of the digital therapeutics market in Spain.

Underlying macroeconomic factors: The increasing prevalence of chronic diseases, an aging population, and rising healthcare costs are driving the demand for innovative and cost-effective healthcare solutions in Spain. Digital therapeutics offer a promising opportunity to address these challenges by providing scalable, evidence-based interventions that can improve patient outcomes and reduce the burden on the healthcare system. Additionally, the growing investment in digital health infrastructure and the rise of telemedicine services are creating a conducive environment for the expansion of the digital therapeutics market in Spain.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.